Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Federal Trade Commission
Mallinckrodt
McKesson
Queensland Health
Fish and Richardson
Accenture
Johnson and Johnson
Farmers Insurance

Generated: January 21, 2019

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: rufinamide

« Back to Dashboard

rufinamide

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Eisai Inc BANZEL rufinamide SUSPENSION;ORAL 201367 NDA Eisai Inc. 62856-584-46 1 BOTTLE in 1 CARTON (62856-584-46) > 460 mL in 1 BOTTLE
Eisai Inc BANZEL rufinamide TABLET;ORAL 021911 NDA Eisai Inc. 62856-582-52 120 TABLET, FILM COATED in 1 BOTTLE (62856-582-52)
Eisai Inc BANZEL rufinamide TABLET;ORAL 021911 NDA Eisai Inc. 62856-583-52 120 TABLET, FILM COATED in 1 BOTTLE (62856-583-52)
Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
US Army
Federal Trade Commission
Colorcon
Medtronic
QuintilesIMS
Baxter
McKinsey
Chinese Patent Office